GliaPharm
GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm has raised €1.9M across 1 funding round, most recently a Seed round in May 2020. Based in Geneva, Switzerland; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.9M
€1,887,327
Funding rounds
1
Investors
0
distinct backers
Active since
2020-05
latest 2020-05
Funding by year
EUR raised per yearGliaPharm — funding by year — interactive chart.
Data table
| GliaPharm — funding by year | |
|---|---|
| 2020 | €1.9M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-05-26 | Seed | €1.9M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData